Back to Search

JEAN DELA CRUZ, MD

MD

Pediatrics Physician

NPI: 1154908457Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

L.5417R(AL)
Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (20)

Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies.
PMID 15908002·Mol Immunol·2006
7-preclinical
Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein.
PMID 15967544·Vaccine·2005
7-preclinical
Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.
PMID 15672942·Clin Exp Med·2004
6-review
Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice.
PMID 12615426·Vaccine·2003
7-preclinical
Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
PMID 11046042·J Immunol·2000
7-preclinical
Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of D-amphetamine and SKF-82958, and their augmentation by food restriction in rat.
PMID 18766328·Psychopharmacology (Berl)·2009
7-preclinical
Isomeric identification by laser control mass spectrometry.
PMID 17173337·J Mass Spectrom·2007
8-other
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
PMID 16479517·J Infect Dis·2006
2-rct
Inositol phosphate metabolomics: merging genetic perturbation with modernized radiolabeling methods.
PMID 16829132·Methods·2006
6-review
Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma.
PMID 16380835·Invest New Drugs·2006
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2451 UNIVERSITY HOSPITAL DR RM 714
MOBILE, AL 36617

Quick Facts

NPI
1154908457
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile